Financial statements Inobiotek
Balance sheet data of INOBIOTEK
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 10 858,51 | 8 815,26 | 13 094,43 | 19 050,98 | 32 828,33 | 2 815,80 |
| A. Fixed assets | 750,00 | 750,00 | 2 030,16 | 2 030,16 | 1 280,16 | 1 280,16 |
| B. Current assets | 10 108,51 | 8 065,26 | 11 064,27 | 17 020,82 | 31 548,17 | 1 535,64 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 10 858,51 | 8 815,26 | 13 094,43 | 19 050,98 | 32 828,33 | 2 815,80 |
| A. Equity | 9 384,06 | 7 330,81 | 11 609,98 | 17 368,53 | 13 525,50 | 1 266,80 |
| B. Liabilities and provisions for liabilities | 1 474,45 | 1 484,45 | 1 484,45 | 1 682,45 | 19 302,83 | 1 549,00 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 474,45 | 1 484,45 | 1 484,45 | 1 682,45 | 19 302,83 | 1 549,00 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.